We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+10.64%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$36.1B
AUM Growth
+$1.87B
(+5.5%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-5.51%
Top 10 Holdings %
Top 10 Hldgs %
9.35%
Holding
920
New
81
Increased
311
Reduced
323
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$77.1M |
| 2 |
Texas Instruments
TXN
|
+$70.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$67.7M |
| 4 |
Apple
AAPL
|
+$63.3M |
| 5 |
Quest Diagnostics
DGX
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$171M |
| 2 |
TWOU
2U Inc
TWOU
|
+$88.9M |
| 3 |
Baxter International
BAX
|
+$81.6M |
| 4 |
MasTec
MTZ
|
+$80.1M |
| 5 |
Abbott
ABT
|
+$76.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.76% |
| 2 | Healthcare | 15.13% |
| 3 | Financials | 13.5% |
| 4 | Industrials | 12.84% |
| 5 | Consumer Discretionary | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Tactile Systems Technology
TCMD
$618M
| $26.2M | 0.07% |
368,374
-17,653
| -5% | -$1.06M |
|
|
EB
402
DELISTED
Eventbrite
EB
| $26.1M | 0.07% |
+686,878
| New | +$24.9M |
|
403
Marvell Technology
MRVL
$147B
| $25.8M | 0.07% |
1,337,978
+87,522
| +7% | +$1.8M |
|
404
Idacorp
IDA
$8B
| $25.7M | 0.07% |
259,325
| – | – |
|
405
Cencora
COR
$62B
| $25.5M | 0.07% |
276,500
+14,300
| +5% | +$1.24M |
|
406
Goosehead Insurance
GSHD
$1.68B
| $25.4M | 0.07% |
750,215
-276,646
| -27% | -$8.02M |
|
407
Analog Devices
ADI
$172B
| $25.1M | 0.07% |
271,887
-161,875
| -37% | -$15.6M |
|
408
Curtiss-Wright
CW
$25.1B
| $24.9M | 0.07% |
181,204
-552
| -0.3% | -$72.4K |
|
409
Eagle Materials
EXP
$6.49B
| $24.8M | 0.07% |
290,608
-355,304
| -55% | -$34.5M |
|
410
Arista Networks
ANET
$199B
| $24.8M | 0.07% |
1,489,744
-56,064
| -4% | -$954K |
|
|
MDSO
411
DELISTED
Medidata Solutions, Inc.
MDSO
| $24.6M | 0.07% |
335,718
+212,428
| +172% | +$17M |
|
412
Denali Therapeutics
DNLI
$3.79B
| $24.5M | 0.07% |
1,125,455
+761,599
| +209% | +$12.6M |
|
413
Ollie's Bargain Outlet
OLLI
$4.31B
| $24.2M | 0.07% |
251,805
-186,478
| -43% | -$14.9M |
|
|
MCRN
414
DELISTED
Milacron Holdings Corp.
MCRN
| $24.1M | 0.07% |
1,191,938
+227,736
| +24% | +$4.61M |
|
|
SFIX
415
Stitch Fix
SFIX
$567M
| $23.9M | 0.07% |
+545,181
| New | +$19.9M |
|
416
MACOM Technology Solutions
MTSI
$17.4B
| $23.8M | 0.07% |
1,154,681
-273,059
| -19% | -$6.12M |
|
|
CDK
417
DELISTED
CDK Global, Inc.
CDK
| $23.6M | 0.07% |
+376,800
| New | +$23.9M |
|
|
IMMU
418
DELISTED
Immunomedics Inc
IMMU
| $23.3M | 0.06% |
1,117,518
-323,441
| -22% | -$7.66M |
|
419
Columbus McKinnon
CMCO
$422M
| $23.2M | 0.06% |
586,314
+33,100
| +6% | +$1.38M |
|
420
Sherwin-Williams
SHW
$84.8B
| $23.1M | 0.06% |
152,475
-8,100
| -5% | -$1.2M |
|
421
Biogen
BIIB
$30.9B
| $23.1M | 0.06% |
+65,425
| New | +$22.5M |
|
422
Sabre
SABR
$716M
| $23.1M | 0.06% |
883,800
+380,500
| +76% | +$9.77M |
|
423
Coca-Cola Europacific Partners
CCEP
$49.1B
| $23M | 0.06% |
505,971
| – | – |
|
424
Axalta
AXTA
$7.45B
| $22.8M | 0.06% |
781,696
-216,957
| -22% | -$6.51M |
|
425
Eli Lilly
LLY
$1.08T
| $22.7M | 0.06% |
+211,626
| New | +$21.2M |
|
Similar funds
Lord, Abbett & Co's Q3 2018 Portfolio in Review
As of Q3 2018, Lord, Abbett & Co held 920 positions worth $36.1B, up 5.5% from $34.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Lord, Abbett & Co withdrew a net $1.99B in Q3 2018, closing 104 positions and reducing 323 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Quest Diagnostics worth $62M.
- Lord, Abbett & Co's largest Q3 2018 buy was Quest Diagnostics: 574,600 shares worth $62M.
- Lord, Abbett & Co added most to Comcast in Q3 2018, an estimated $77.1M increase.
- Lord, Abbett & Co's biggest Q3 2018 reduction was 2U Inc, cutting an estimated $88.9M.
- Lord, Abbett & Co fully exited Meta Platforms (Facebook) in Q3 2018, selling an estimated $171M.
- Lord, Abbett & Co's ten largest holdings make up 9.3% of its $36.1B portfolio in Q3 2018.
- Lord, Abbett & Co opened 81 new positions and closed 104 in Q3 2018.
- Lord, Abbett & Co's portfolio value rose 5.5% quarter-over-quarter to $36.1B.
Based on Lord, Abbett & Co's 13F filing for Q3 2018, filed 14 Nov 2018.